E. DOĞAN Et Al. , "INVESTIGATION OF THE FREQUENCY OF ADVERSE EFFECTS IN HOSPITALIZED PATIENTS USING FAVIPIRAVIR FOR SARS-CoV-2," MedicReS GMR 2020 , digital, 2020
DOĞAN, E. Et Al. 2020. INVESTIGATION OF THE FREQUENCY OF ADVERSE EFFECTS IN HOSPITALIZED PATIENTS USING FAVIPIRAVIR FOR SARS-CoV-2. MedicReS GMR 2020 , (digital) .
DOĞAN, E., ALKAN ÇEVİKER, S., VURUCU, S., ŞENER, A., Yüksel, B., GÖNLÜGÜR, U., ... ŞİMŞEK, T.(2020). INVESTIGATION OF THE FREQUENCY OF ADVERSE EFFECTS IN HOSPITALIZED PATIENTS USING FAVIPIRAVIR FOR SARS-CoV-2 . MedicReS GMR 2020, digital
DOĞAN, EBRU Et Al. "INVESTIGATION OF THE FREQUENCY OF ADVERSE EFFECTS IN HOSPITALIZED PATIENTS USING FAVIPIRAVIR FOR SARS-CoV-2," MedicReS GMR 2020, digital, 2020
DOĞAN, EBRU Et Al. "INVESTIGATION OF THE FREQUENCY OF ADVERSE EFFECTS IN HOSPITALIZED PATIENTS USING FAVIPIRAVIR FOR SARS-CoV-2." MedicReS GMR 2020 , digital, 2020
DOĞAN, E. Et Al. (2020) . "INVESTIGATION OF THE FREQUENCY OF ADVERSE EFFECTS IN HOSPITALIZED PATIENTS USING FAVIPIRAVIR FOR SARS-CoV-2." MedicReS GMR 2020 , digital.
@conferencepaper{conferencepaper, author={EBRU DOĞAN Et Al. }, title={INVESTIGATION OF THE FREQUENCY OF ADVERSE EFFECTS IN HOSPITALIZED PATIENTS USING FAVIPIRAVIR FOR SARS-CoV-2}, congress name={MedicReS GMR 2020}, city={digital}, country={}, year={2020}}